Overview
Monika Denk practices in Tuebingen, Germany. Ms. Denk is rated as an Advanced expert by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Leukemia.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Fibrolamellar Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Fibrolamellar CarcinomaMs. Denk isAdvanced. Learn about Fibrolamellar Carcinoma.
- Experienced
- Brain TumorMs. Denk isExperienced. Learn about Brain Tumor.
- Chronic B-Cell Leukemia (CBCL)Ms. Denk isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Denk isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- GliomaMs. Denk isExperienced. Learn about Glioma.
- LeukemiaMs. Denk isExperienced. Learn about Leukemia.
- Liver CancerMs. Denk isExperienced. Learn about Liver Cancer.